Sign In
Buy MNK
$0.116
+0 (+0%)
At Close: Jul 20, 2022
BRIEF-Mallinckrodt Announces U.S. FDA Filing Acceptance Of New Drug Application Treatment Of Hepatorenal Syndrome
11:59am, Wednesday, 22'nd Apr 2020
Mallinckrodt Plc:
<![CDATA[Cuomo and Trump talk testing — NYC promises parade for health care workers — City to temporarily freeze some remains]]>
11:58am, Wednesday, 22'nd Apr 2020
Farewell, Comfort.
That’s one takeaway from Gov. Andrew Cuomo’s sitdown Tuesday with Donald Trump, where the president asked “Andrew” if New York would be willing to
relinquish the Navy ship
t
Mallinckrodt reports FDA acceptance of NDA for terlipressin MNK
11:17am, Wednesday, 22'nd Apr 2020
Mallinckrodt reports FDA acceptance of NDA for terlipressin MNK
Mallinckrodt plc (NYSE: MNK), a global biopharmaceutical company, today announced that the U.S. Food and Drug Administration (FDA) has accepted for review the company's New Drug Application (NDA) for
New York charges Mallinckrodt with insurance fraud over opioid claims
06:54pm, Tuesday, 21'st Apr 2020
NEW YORK — New York state brought civil charges on Tuesday accusing Mallinckrodt Plc of insurance fraud for misrepresenting the safety and efficacy of its opioid drugs, leading to medically u…
UPDATE 3-New York charges Mallinckrodt with insurance fraud over opioid claims
06:52pm, Tuesday, 21'st Apr 2020
New York state brought civil charges on Tuesday accusing Mallinckrodt Plc of insurance fraud for misrepresenting the safety and efficacy of its opioid drugs, leading to medically unnecessary prescript
New York charges Mallinckrodt with insurance fraud over opioid claims
05:56pm, Tuesday, 21'st Apr 2020
New York state brought civil charges on Tuesday accusing Mallinckrodt Plc of insurance fraud for misrepresenting the safety and efficacy of its opioid drugs, leading to medically unnecessary prescript
New York charges Mallinckrodt with insurance fraud over opioid claims
05:53pm, Tuesday, 21'st Apr 2020
NEW YORK — New York state brought civil charges on Tuesday accusing Mallinckrodt Plc of insurance fraud for misrepresenting the safety and efficacy of its opioid drugs, leading to medically u…
New York charges Mallinckrodt with insurance fraud related to opioids
04:37pm, Tuesday, 21'st Apr 2020
New York state charged Mallinckrodt Plc on Tuesday with insurance fraud for misrepresenting the safety and efficacy of its opioid drugs, leading to medically unnecessary prescriptions.
UPDATE 1-New York charges Mallinckrodt with insurance fraud related to opioids
04:35pm, Tuesday, 21'st Apr 2020
(Adds allegations, stock price)
New York charges Mallinckrodt with insurance fraud over opioid claims
04:19pm, Tuesday, 21'st Apr 2020
New York state brought civil charges on Tuesday accusing Mallinckrodt Plc of insurance fraud for misrepresenting the safety and efficacy of its opioid drugs, leading to medically unnecessary prescript
New York charges Mallinckrodt with insurance fraud related to opioids
04:07pm, Tuesday, 21'st Apr 2020
New York has charged Mallinckrodt Plc with insurance fraud for misrepresenting the safety and efficacy of its opioid drugs, leading to medically unnecessary prescriptions.
New York charges Mallinckrodt with insurance fraud related to opioids
03:57pm, Tuesday, 21'st Apr 2020
NEW YORK, April 21 (Reuters) - New York has charged Mallinckrodt Plc with insurance fraud for misrepresenting the safety and efficacy of its opioid drugs, leading to medically unnecessary prescription
Stocks - Dow Down as Bears Sink Teeth Into Tech Amid Oil Plunge
01:18pm, Tuesday, 21'st Apr 2020
By Yasin Ebrahim
